Stifel Nicolaus Increases Colgate-Palmolive (NYSE:CL) Price Target to $95.00

Colgate-Palmolive (NYSE:CL) had its price target increased by investment analysts at Stifel Nicolaus from $94.00 to $95.00 in a research note issued on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective indicates a potential upside of 3.37% from the stock’s current price.

Several other equities research analysts have also weighed in on CL. UBS Group upped their price objective on Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, January 29th. Bank of America increased their price target on Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research report on Monday. Royal Bank of Canada increased their price target on Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Monday. Barclays increased their price target on Colgate-Palmolive from $82.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Friday, April 12th. Finally, TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $91.44.

Colgate-Palmolive Trading Up 1.6 %

Shares of CL opened at $91.90 on Monday. Colgate-Palmolive has a 12-month low of $67.62 and a 12-month high of $92.25. The company has a quick ratio of 0.28, a current ratio of 0.42 and a debt-to-equity ratio of 8.59. The firm has a market capitalization of $75.54 billion, a price-to-earnings ratio of 29.08, a P/E/G ratio of 3.42 and a beta of 0.42. The stock’s 50-day moving average price is $87.95 and its 200 day moving average price is $81.92.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. During the same period in the prior year, the company posted $0.73 EPS. The company’s revenue was up 6.2% compared to the same quarter last year. As a group, research analysts predict that Colgate-Palmolive will post 3.5 earnings per share for the current year.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the transaction, the chief executive officer now directly owns 274,179 shares in the company, valued at approximately $22,797,983.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the transaction, the chief executive officer now owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Gregory Malcolm sold 8,930 shares of the stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $85.35, for a total value of $762,175.50. Following the completion of the transaction, the executive vice president now directly owns 8,043 shares in the company, valued at approximately $686,470.05. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 229,611 shares of company stock worth $19,271,879. Insiders own 0.37% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Vest Financial LLC raised its stake in Colgate-Palmolive by 25.1% during the 4th quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after buying an additional 74,337 shares during the period. Central Bank & Trust Co. raised its stake in Colgate-Palmolive by 22.1% during the 4th quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock worth $110,000 after buying an additional 250 shares during the period. Dynamic Advisor Solutions LLC raised its stake in Colgate-Palmolive by 9.2% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock worth $864,000 after buying an additional 910 shares during the period. Sarasin & Partners LLP raised its stake in Colgate-Palmolive by 1.2% during the 4th quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after buying an additional 49,980 shares during the period. Finally, Cornerstone Wealth Management LLC raised its stake in Colgate-Palmolive by 2.5% during the 4th quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after buying an additional 172 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.